The role of the antioxidant and longevity-promoting Nrf2 pathway in metabolic regulation

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 14, Issue 1, 2011, Pages 41-48

  Sykiotis, Gerasimos P ^b   Habeos, Ioannis G ^b   Samuelson, Andrew V ^a   Bohmann, Dirk ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

Aging; Calorie restriction; Diabetic nephropathy; Insulin signaling; Nrf2; Obesity

Indexed keywords

GLUTATHIONE; INSULIN; PROTEIN KINASE B; THIOREDOXIN; TRANSCRIPTION FACTOR NRF2;

ADIPOGENESIS; AGING; ANTIOXIDANT ACTIVITY; ARTICLE; CALORIC RESTRICTION; CONCENTRATION RESPONSE; DIABETIC NEPHROPATHY; DRUG MECHANISM; LIPID METABOLISM; LONGEVITY; METABOLIC REGULATION; MOLECULAR INTERACTION; NONHUMAN; OBESITY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS;

ANIMALS; ANTIOXIDANTS; CALORIC RESTRICTION; DIABETIC NEPHROPATHIES; ENERGY METABOLISM; GENE EXPRESSION; GENE EXPRESSION REGULATION; LONGEVITY; METABOLIC DISEASES; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

INVERTEBRATA; VERTEBRATA;

EID: 79851508187     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e32834136f2     Document Type: Article

References (64)

1. Calkins MJ, Johnson DA, Townsend JA, et al. The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxid Redox Signal 2009; 11:497-508.
2. Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 2007; 47:89-116.
3. Kobayashi M, Yamamoto M. Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Adv Enzyme Regul 2006; 46:113-140. (Pubitemid 44301353)
4. Sykiotis GP, Bohmann D. Stress-activated Cap'n'collar transcription factors in aging and human disease. Sci Signal 2010; 3:re3.
5. Lee JM, Li J, Johnson DA, et al. Nrf2, a multiorgan protector? FASEB J 2005; 19:1061-1066.
6. Zhang DD. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev 2006; 38:769-789. (Pubitemid 44903268)
7. Li W, Kong AN. Molecular mechanisms of Nrf2-mediated antioxidant response. Mol Carcinog 2009; 48:91-104.
8. Kaspar JW, Niture SK, Jaiswal AK. Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med 2009; 47:1304-1309.
9. Kobayashi A, Kang MI, Okawa H, et al. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 2004; 24:7130-7139. (Pubitemid 39014439)
10. Zhang DD, Lo SC, Cross JV, et al. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol Cell Biol 2004; 24:10941-10953. (Pubitemid 39603148)
11. Motohashi H, Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med 2004; 10:549-557. (Pubitemid 39433824)
12. Harman D. Free radical theory of aging: an update - increasing the functional life span. Ann N Y Acad Sci 2006; 1067:10-21. (Pubitemid 43806304)
13. Sykiotis GP, Bohmann D. Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in Drosophila. Dev Cell 2008; 14:76-85.
14. Tullet JMA, Hertweck M, An JH, et al. Direct inhibition of the longevity promoting factor SKN-1 by insulinlike signaling in C. elegans. Cell 2008; 132:1025-1038. (Pubitemid 351391953)
15. Bishop NA, Guarente L. Genetic links between diet and lifespan: shared mechanisms from yeast to humans. Nat Rev Genet 2007; 8:835-844. (Pubitemid 47609089)
16. Partridge L, Pletcher SD, Mair W. Dietary restriction, mortality trajectories, risk and damage. Mech Ageing Dev 2005; 126:35-41. (Pubitemid 40018475)
17. Katic M, Kahn CR. The role ofinsulin and IGF-1 signaling in longevity. Cell Mol Life Sci 2005; 62:320-343. (Pubitemid 40379247)
18. Min KJ, Yamamoto R, Buch S, et al. Drosophila lifespan control by dietary restriction independent of insulin-like signaling. Aging Cell 2008; 7:199-206. (Pubitemid 351359653)
19. Fontana L, Partridge L, Longo VD. Extending healthy life span: from yeast to humans. Science 2010; 328:321-326.
20. Shih PH, Yen GC. Differential expressions of antioxidant status in aging rats: the role of transcriptional factor Nrf2 and MAPK signaling pathway. Biogerontology 2007; 8:71-80.
21. Suh JH, Shenvi SV, Dixon BM, et al. Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci U S A 2004; 101:3381-3386. (Pubitemid 38338203)
22. Pearson KJ, Lewis KN, Price NL, et al. Nrf2 mediates cancer protection butnot prolongevity induced by caloric restriction. Proc Natl Acad Sci U S A 2008; 105:2325-2330. (Pubitemid 351520512)
23. Gross L, Dreyfuss Y. Reduction in the incidence of radiation-induced tumors in rats after restriction of food intake. Proc Natl Acad Sci U S A 1984; 81:7596-7598. (Pubitemid 15196230)
24. Weindruch R, Walford RL, Fligiel S, Guthrie D. The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy intake. J Nutr 1986; 116:641-654. (Pubitemid 16066430)
25. Bishop NA, Guarente L. Two neurons mediate diet-restriction-induced longevity in C. elegans. Nature 2007; 447:545-549. (Pubitemid 46868049)
26. Redman LM, Ravussin E. Caloric restriction in humans: impact on physiological, psychological and behavioral outcomes. Antioxid Redox Signal 2010. [Epub ahead of print]
27. Mehta LH, Roth GS. Caloric restriction and longevity: the science and the ascetic experience. Ann N Y Acad Sci 2009; 1172:28-33.
28. Lane MA, Roth GS, Ingram DK. Caloric restriction mimetics: a novel approach for biogerontology. Methods Mol Biol 2007; 371:143-149. (Pubitemid 350183423)
29. Milne JC, Lambert PD, Schenk S, et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 2007; 450:712-716. (Pubitemid 350207685)
30. Wood JG, Rogina B, Lavu S, et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004; 430:686-689. (Pubitemid 39061685)
31. Chen CY, Jang JH, Li MH, Surh YJ. Resveratrol upregulates heme oxygenase- 1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem Biophys Res Commun 2005; 331:993-1000.
32. Kode A, Rajendrasozhan S, Caito S, et al. Resveratrol induces glutathione synthesis byactivation of Nrf2 and protects againstcigarette smoke-mediated oxidative stress in human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 2008; 294:L478-L488. (Pubitemid 351468847)
33. Onken B, Driscoll M. Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans healthspan via AMPK, LKB1, and SKN-1. PLoS One 2010; 5:e8758.
34. Bluher M, Kahn BB, Kahn CR. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 2003; 299:572-574. (Pubitemid 36135156)
35. Clancy DJ, Gems D, Harshman LG, et al. Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 2001; 292:104-106. (Pubitemid 32289136)
36. Kenyon C. The plasticity ofaging: insights from long-lived mutants. Cell 2005; 120:449-460. (Pubitemid 40269760)
37. Samuelson AV, Carr CE, Ruvkun G. Gene activities that mediate increased life span of C. e/egans insulin-like signaling mutants. Genes Dev 2007; 21:2976-2994. (Pubitemid 350133444)
38. Salih DA, Brunet A. FoxO transcription factors in the maintenance of cellular homeostasis during aging. Curr Opin Cell Biol 2008; 20:126-136.
39. van der Horst A, Burgering BM. Stressing the role of FoxO proteins in lifespan and disease. Nat Rev Mol Cell Biol 2007; 8:440-450. (Pubitemid 46809159)
40. Junger MA, Rintelen F, Stocker H, et al. The Drosophila forkhead transcription factor FOXO mediates the reduction in cell number associated with reduced insulin signaling. J Biol 2003; 2:20.
41. Puig O, Tjian R. Transcriptional feedback control of insulin receptor by dFOXO/FOXO1. Genes Dev 2005; 19:2435-2446. (Pubitemid 41483691)
42. Okawa H, Motohashi H, Kobayashi A, et al. Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. Biochem Biophys Res Commun 2006; 339:79-88. (Pubitemid 41697517)
43. Malhotra D, Portales-Casamar E, Singh A, et al. Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChlP- Seq profiling and network analysis. Nucleic Acids Res 2010; 38:5718-5734.
44. Kwak MK, Wakabayashi N, Itoh K, et al. Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival. J Biol Chem 2003; 278:8135-8145. (Pubitemid 36800555)
45. Shin S, Wakabayashi J, Yates MS, et al. Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide. Eur J Pharmacol 2009; 620:138-144.
46. Kitteringham NR, Abdullah A, Walsh J, et al. Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver. J Proteomics 2010; 73:1612-1631.
47. D'Archivio M, Scazzocchio B, Filesi C, et al. Oxidised LDL up-regulate CD36 expression by the Nrf2 pathway in 3T3-L1 preadipocytes. FEBS Lett 2008; 582:2291-2298.
48. Gao L, Wang J, Sekhar KR, et al. Novel n-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between Keap1 and Cullin3. J Biol Chem 2007; 282:2529-2537. (Pubitemid 47076775)
49. Levonen AL, Landar A, Ramachandran A, et al. Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. Biochem J 2004; 378 (Pt 2):373-382. (Pubitemid 38367228)
50. Yates MS, Tran QT, Dolan PM, et al. Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keapl knockout and triterpenoid-treated mice. Carcinogenesis 2009; 30:1024-1031.
51. Chowdhry S, Nazmy MH, Meakin PJ, et al. Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis. Free Radic Biol Med 2010; 48:357-371.
52. Sugimoto H, Okada K, Shoda J, et al. Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice. Am J Physiol Gastrointest Liver Physiol 2009; 298:G283-294.
53. Zhang YK, Yeager RL, Tanaka Y, Klaassen CD. Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet. Toxicol Appl Pharmacol 2010; 245:326-334.
54. Tanaka Y, Aleksunes LM, Yeager RL, et al. NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet. J Pharmacol Exp Ther 2008; 325:655-664. (Pubitemid 351574806)
55. Shin S, Wakabayashi N, Misra V, et al. NRF2 modulates aryl hydrocarbon receptor signaling: influence on adipogenesis. Mol Cell Biol 2007; 27:7188-7197. (Pubitemid 47549754)
56. Pi J, Leung L, Xue P, et al. Deficiency in the nuclear factor E2-related factor-2 transcription factor results in impaired adipogenesis and protects againstdiet-induced obesity. J Biol Chem 2010; 285:9292-9300.
57. Cho HY, Reddy SP, Debiase A, et al. Gene expression profiling of NRF2-mediated protection against oxidative injury. Free Radic Biol Med 2005; 38:325-343. (Pubitemid 40081112)
58. Milder JB, Liang LP, Patel M. Acute oxidative stress and systemic Nrf2 activation by the ketogenic diet. Neurobiol Dis 2010; 40:238-244.
59. Habeos IG, Ziros PG, Chartoumpekis D, et al. Simvastatin activates Keap1/Nrf2 signaling in rat liver. J Mol Med 2008; 86:1279-1285.
60. Hsieh CH, Rau CS, Hsieh MW, et al. Simvastatin-induced heme oxygenase-1 increases apoptosis of Neuro 2A cells in response to glucose deprivation. Toxicol Sci 2008; 101:112-121.
61. Chartoumpekis D, Ziros PG, Psyrogiannis A, et al. Simvastatin lowers reactive oxygen species level by Nrf2 activation via PI3K/Akt pathway. Biochem Biophys Res Commun 2010; 396:463-466.
62. Aleksunes LM, Reisman SA, Yeager RL, et al. Nuclear factor erythroid 2-related factor 2 deletion impairs glucose tolerance and exacerbates hyper-glycemia in type 1 diabetic mice. J Pharmacol Exp Ther 2010; 333:140-151.
63. Jiang T, Huang Z, Lin Y, et al. The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy. Diabetes 2010; 59:850-860.
64. Yoh K, Hirayama A, Ishizaki K, et al. Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2-deficient mice. Genes Cells 2008; 13:1159-1170.